Bert Grobben

Dr. Bert Grobben is a seasoned executive in the biotechnology and innovation sectors, currently serving as the Chief Executive Officer and Executive Commercial Director of ArrowBiome, a pioneering company in selective bacterial targeting within the human microbiome. Additionally, Dr. Grobben holds multiple advisory and leadership roles, including CEO of Budding Innovation, Adjunct Associate Professor at the National University of Singapore, and Business Expansion Lead APAC for Bio-Recell. Dr. Grobben is also involved with various organizations, such as Agilis Design, REVIVO BioSystems, and Greenitio, where expertise in business development and innovation management is leveraged. Dr. Grobben’s academic background includes a Master's degree and PhD in Biomedical Sciences from the University of Antwerp.